Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro.
M Baba, R Pauwels, P Herdewijn, E De Clercq, J Desmyter, M Vandeputte
Index: Biochem. Biophys. Res. Commun. 142 , 128, (1987)
Full Text: HTML
Abstract
2',3'-Dideoxythymidine (ddThd) and its 2',3'-unsaturated derivative 2',3'-dideoxythymidinene (ddeThd) are potent and selective inhibitors of human immunodeficiency virus (HIV) in vitro. When evaluated for their inhibitory effects on the cytopathogenicity of HIV in MT-4 cells, ddThd and ddeThd completely protected the cells against destruction by the virus at a concentration of 1 microM and 0.04 microM, respectively. In this aspect, ddeThd was about 5 times more potent than 2',3'-dideoxycytidine (ddCyd), one of the most potent and selective anti-HIV compounds now pursued for its therapeutic potential in the treatment of AIDS. ddThd and ddeThd also suppressed HIV antigen expression at 1 microM and 0.04 microM, respectively. Their selectivity indexes, as based on the ratio of the 50% cytotoxic dose to the 50% antiviral effective dose, were 120 (ddeThd) and greater than 625 (ddThd).
Related Compounds
Related Articles:
2015-01-01
[PLoS ONE 10(4) , e0123460, (2015)]
2014-09-01
[Antimicrob. Agents Chemother. 58(9) , 5036-46, (2014)]
2015-10-27
[ACS Nano 9 , 10214-26, (2015)]
1991-10-01
[Antimicrob. Agents Chemother. 35(10) , 2003-11, (1991)]
1989-07-01
[Mol. Pharmacol. 36(1) , 185-92, (1989)]